VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 106 filers reported holding VENTYX BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $916,872 | +5.9% | 26,400 | 0.0% | 0.78% | +20.2% |
| Q2 2023 | $865,920 | +97854.8% | 26,400 | 0.0% | 0.65% | -6.2% |
| Q1 2023 | $884 | +22.6% | 26,400 | +20.0% | 0.69% | +36.0% |
| Q4 2022 | $721 | -100.0% | 22,000 | -51.1% | 0.51% | -54.0% |
| Q3 2022 | $1,571,000 | +288.9% | 45,000 | +36.4% | 1.11% | +276.2% |
| Q2 2022 | $404,000 | +19.2% | 33,000 | +32.0% | 0.29% | +20.5% |
| Q1 2022 | $339,000 | -31.8% | 25,000 | 0.0% | 0.24% | -23.8% |
| Q4 2021 | $497,000 | – | 25,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
| TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
| ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
| Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
| Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
| Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
| Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
| Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
| Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |